Switch of transforming growth factor β function from tumor suppression to stimulation in adenomatous polyposis coli (APC) knocked-down human colon carcinoma cells

Cancer Letters

Volumn 272, Issue 2, 2008, Pages 253-259

  Wang, Hongmei ^a   Promkan, Moltira ^a   Liu, Guangming ^a   Chakrabarty, Subhas ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

catenin Wnt; APC; Colon cancer; TGF ; Tumor promotion; Tumor suppression

Indexed keywords

APC PROTEIN; BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; WNT PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL INVASION; COLON CARCINOMA; COLON POLYPOSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR PROMOTION;

BASE SEQUENCE; CELL LINE, TUMOR; COLONIC NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; GENES, APC; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 55949094275     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.07.010     Document Type: Article

References (29)

1. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L.-Z., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., Vogelstein B., Brattain M.G.B., and Willson J.K.V. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268 (1995) 1336-1338
2. Brattain M.G., Markowitz S.D., and Willson J.K. The type II transforming growth factor-beta receptor as a tumor-suppressor gene. Curr. Opin. Oncol. 8 (1996) 49-53
3. Brunschwig E.B., Wilson K., Mack D., Dawson D., Lawrence E., Willson J.K.V., Lu S., Nosrati A., Rerko M., Swinler S., Beard L., Lutterbaugh J.D., Willis J., Platzer P., and Markowitz S. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Cancer Res. 63 (2003) 1568-1575
4. Chakrabarty S., and Wang H. Cellular adhesion and control of colon epithelial cell growth and differentiation: role of transforming growth factor and the calcium sensing receptor. J. Clin. Ligand Assay 27 (2004) 104-111
5. Brattain M.G., Levine A.E., Chakrabarty S., Yeoman L.C., Willson J.K.V., and Long B.H. Heterogeneity of human colon carcinoma. Cancer Met. Rev. 3 (1984) 177-191
6. Chakrabarty S. Regulation of human colon carcinoma cell adhesion to extracellular matrix by transforming growth factor-β. Int. J. Cancer 50 (1992) 968-973
7. Gong J.G., Ammanamanchi S., Ko T.C., and Brattain M.G. Transforming growth factor-β1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Cancer Res. 63 (2003) 3340-3346
8. Wang H., Radjendirane V., Wary K.K., and Chakrabarty S. Transforming growth factor regulates cell--cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells. Oncogene 23 (2004) 5558-5561
9. Chakrabarty S., Rajagopal S., and Moskal T.L. Protein kinase Cα controls the adhesion but not the antiproliferative response of human colon carcinoma cells to transforming growth factor β1: identification of two distinct branches of post-protein kinase Cα adhesion signal pathway. Lab. Invest. 78 (1998) 413-421
10. Huang S., and Chakrabarty S. Regulation of fibronectin and laminin receptor expression, fibronectin and laminin secretion in human colon cancer cells by transforming growth factorβ1. Int. J. Cancer 57 (1994) 742-746
11. Wang H., and Chakrabarty S. Requirement of protein kinase Cα, extracellular matrix remodeling and cell-matrix interaction for transforming growth factor-regulated expression of E-cadherin and catenins. J. Cell. Physiol. 187 (2001) 188-195
12. Chakrabarty S., Jan Y., Brattain M.G., Tobon A., and Varani J. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β. Cancer Res. 49 (1989) 2112-2117
13. Chakrabarty S., Fan D., and Varani J. Regulation of differentiation and cellular proliferation in human colon carcinoma cells by transforming growth factor beta 1 and beta 2. Int. J. Cancer 46 (1990) 493-499
14. Massague J. Receptors of the TGFβ family. Cell 69 (1992) 1067-1070
15. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., and Arteaga C.L. Phosphatidylinositol 3-Kinase function Is required for Transforming Growth Factor β-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275 (2000) 36803-36810
16. Muraoka-Cook R.S., Kurokawa H., Koh Y., Forbes J.T., Roebuck L.R., Barcellos-Hoff M.H., Moody S.E., Chodosh L.A., and Arteaga C.L. Conditional overexpression of active transforming growth factor β1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res. 64 (2004) 9002-9011
17. Friese M.A., Wischhusen J., Wick W., Weiler M., Eisele G., Steinle A., and Weller M. RNA interference targeting transforming growth factor-β enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res. 64 (2004) 7596-7603
18. Lu S.L., Reh D., Li A.G., Woods J., Corless C.L., Kulesz-Martin M., and Wang X.J. Overexpression of transforming growth factor β1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res. 64 (2004) 4405-4410
19. Ao M., Williams K., Bhowmick N.A., and Hayward S.W. Transforming growth factor-β promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res. 66 (2006) 1016-8007
20. Rees J.R.E., Onwuegbusi B.A., Save V.E., Alderson D., and Fitzgerald R.C. In vivo and in vitro evidence for transforming growth factor-β1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res. 66 (2006) 9583-9590
21. Wang H., Rajan S., Liu G., and Chakrabarty S. Transforming growth factor β suppresses β-catenin/Wnt signaling and stimulates an adhesion response in human colon carcinoma cells in a Smad4/DPC4 independent manner. Cancer Lett. 264 (2008) 281-287
22. Yu L., Hebert M.C., and Zhang Y.E. TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J. 21 (2002) 3749-3759
23. Lagna G., Hata A., Hemmati-Brivanlou A., and Massague J. Partnership between DPC4 and SMAD proteins in TGF-beta signaling pathways. Nature 383 (1996) 832-836
24. Chakrabarty S., Radjendirane V., Appelman H., and Varani J. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of β-catenin/TCF activation. Cancer Res. 63 (2003) 67-71
25. 3. Cancer Res. 65 (2005) 398-493
26. Fodde R., Smits R., and Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1 (2001) 55-67
27. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275 (1997) 1787-1790
28. Faux M.C., Ross J.L., Meeker C., Johns T., Ji H., Simpson R.J., Layton M.J., and Burgess A.W. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J. Cell Sci. 117 (2004) 427-439
29. Reynolds S., Rajagopal S., and Chakrabarty S. Differentiation-inducing effect of retinoic acid, difluoromethylornithine, sodium butyrate and sodium suramin in human colon cancer cells. Cancer Lett. 134 (1998) 53-60